"Resolving spatiotemporal pH changes non-invasively in vivo using hyperpolarized pH sensor compounds"
Many efforts have been undertaken to develop an imaging method to characterize hypoxic and acidic regions within tumors, namely a quantitative non-invasive pH imaging technique. However, so far, no technique to non-invasively image extracellular pH has been applicable routinely in the clinic. In humans, pH is mainly regulated by the carbon dioxide/bicarbonate buffer within a narrow pH range, in the blood between pH 7.35 and 7.45. Locally, deviations from the systemic pH are often caused by pathologies, such as cancer, inflammation, infection, ischemia, renal failure or pulmonary disease. Our team identified the pH-sensitive molecule [1,5-13C2]zymonic acid (ZA) which we recently reported in a publication in Nature Communications (Figure 1).
To increase the sensitivity in 13C experiments, we developed a hyperpolarization protocol for ZA. Results in vivo in kidneys and tumors (Figure 2) clearly demonstrate that ZA represents a feasible novel candidate for pH imaging with advantages over existing methods. The demonstrated robustness of using ZA for extracellular pH imaging, its lack of toxicity and its accuracy render this new pH imaging technique promising for further development.